PLSG Invests $20,000 in Clinical Platform, Inc.
Summary
PITTSBURGH, June 6, 2019 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG) placed a $20,000 investment in Clinical Platform, Inc., a Pittsburgh-based, developmental stage, healthcare IT company whose goal is to improve outcomes of cancer patients by providing easily accessible and retainable information on diagnosis and treatment of cancer and connecting them to appropriate clinical trials. "At Clinical Platform, we believe better education means better outcomes," said Michael Maxin, Chief Executive Officer, "and we have just recently launched PediatricCancerlibrary.com in collaboration with UPMC Childrens Hospital of Pittsburgh. "Weve seen an exceptional response from both physicians and users, this is a very exciting time for the company," said Maxin. Cancer remains the second most common cause of death in the U.S. A major issue is the lack of awareness about clinical trials among patients. "This is just the type of innovation in life sciences that the PLSG was designed to support.